Effects of sustained (±) pindolol administration on serotonin neurotransmission in rats

Journal of Psychiatry and Neuroscience

Volumn 25, Issue 4, 2000, Pages 378-388

  Haddjeri, N ^a   Blier, P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antidepressant agents; Depression; Lysergic acid diethylamide; Pindolol; Rats; Receptors; Serotonin; Sprague Dawley

Indexed keywords

LYSERGIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; SEROTONIN RECEPTOR; SEROTONIN; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DESENSITIZATION; DRUG EFFECT; INTRINSIC SYMPATHOMIMETIC ACTIVITY; MICROIONTOPHORESIS; NEUROTRANSMITTER RELEASE; NONHUMAN; POSTSYNAPTIC INHIBITION; PYRAMIDAL NERVE CELL; RAT; RECEPTOR AFFINITY; RECEPTOR BLOCKING; SEROTONIN RELEASE; ANIMAL; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ANIMALS; MALE; PINDOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; SYNAPTIC TRANSMISSION;

EID: 0033623208     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Current advances and trends in the treatment of depression
2. The serotonin hypothesis of major depression
3. The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments
4. The use of pindolol to potentiate antide pressant medication
5. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: A doubled-blind, placebo-controlled trial
6. The use of pindolol with fluoxetine in the treatment of major depression: Final results from a double-blind, placebo-controlled trial
7. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: Intermediate analysis of double-blind, placebo-controlled trial
8. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment
9. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression
10. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance
11. Paroxetine and pindolol: A randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency
12. How long should pindolol be associated with paroxetine to improve the antidepressant response?
13. Faster onset of fluvoxamine in combination with pindolol in the treatment of delusional depression
14. Effect of pindolol on the function of pre- and postsynaptic 5-HT(1A) receptors: In vivo microdialysis and electrophysiological studies in the rat brain
15. 5-HT(1A) autoreceptors and the mode of action of selective serotonin reuptake inhibitor (SSRI)
16. Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin(1A) (5-HT(1A)) receptors
17. Pindolol suppresses serotonergic neuronal activity (by a WAY 100635-sensitive mechanism) and does not block the neuronal inhibition produced by 8-OH-DPAT in awake cats
18. Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT(1A) autoreceptor
19. Modulation of the firing activity of dorsal raphe 5-HT neurons and locus coeruleus NA neurons by (±)pindolol
20. Feedback regulation of central monoaminergic neurons: Evidence from single cell recording studies
21. Electrophysiology of hippocampal neurons. II. After potentials and repetitive firing
22. Behavioral correlates and firing repertoires of neurons in the dorsal hippocampal formation and septum of unrestrained rats
23. Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from dorsal raphe nucleus
24. In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotoninergic terminals
25. 2+-dependent 5-hydroxytryptamine release from neurons of the rat brain cortex
26. 3[H]-serotonin release in rat hypothalamic slices
27. Modification of 5-HT neuron properties by sustained administration of the 5-HT(1A) agonist gepirone: Electrophysiological studies in the rat brain
28. 1 receptor antagonist BMY 7378 on the 5-HT neurotransmission: Electrophysiological studies in the rat central nervous system
29. Differential properties of pre and postsynaptic 5-hydroxytryptamine(1A) receptors in the dorsal raphe and hippocampus: I. Effect of spiperone
30. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT(1A) receptors
31. 5-HT receptors: Subtypes and second messengers
32. 3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus
33. Food intake, neuroendocrine and temperature effects of 8-OH-DPAT in the rat
34. Pharmacology of the hypothermic response to 5-HT(1A) receptor activation in humans
35. Serotonin(1A) receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses
36. Pindolol blocks the inhibitory effect of gepirone, a 5-HT(1A) agonist, on the firing of serotonergic dorsal raphe neurons in the rat brain slice
37. Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-HT neurotransmission
38. Anxiolytic 5-hydroxytryptamine(1A) agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: Single-unit study in unaesthetized, unrestrained rats
39. Agonist occupation of serotonin(1A) receptors in the rat hippocampus prevent their inactivation by pertussis toxin
40. Effect of longterm treatment with the partial 5-HT(1A) receptor agonist flesinoxan on the 5-HT neurotransmission
41. Antagonist properties of (-)pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT(1A) receptors in the rat brain
42. The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotonergic neurons in rats is attenuated by lesion of the frontal cortex
43. An electrophysilogical and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat
44. Role of the medial prefrontal cortex in 5-HT(1A) receptor-induced inhibition of 5-HT neuronal activity in the rat
45. Alterations of central serotonergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: Biochemical and electrophysiological studies
46. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine- II: Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenaline neurotransmission
47. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine-I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission
48. Alteration of 5-HT(1A) receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography
49. Effect of acute and repeated versus sustained administration of the 5-HT(1A) receptor agonist ipsapirone: Electrophysiological studies in the rat hippocampus and dorsal raphe
50. Full agonistic properties of Bay X 3702 on presynaptic and postsynaptic 5-HT(1A) receptors: Electrophysiological studies in the rat hippocampus and dorsal raphe
51. Autoradiographic quantification of serotonin(1A) receptors in rat brain following antidepressant drug treatment
52. Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors
53. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT(1A) receptor antagonist
54. Quantified distribution of the serotonin innervation in adult rat hippocampus
55. Immunocytochemical localization of serotonin(1A) receptors in the rat central nervous system
56. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
57. 5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: Modulation by pindolol
58. Serotonin (5-HT) release in the dorsal raphe and ventral hippocampus: Raphe control of somatodendritic and terminal 5-HT release
59. (-)Pindolol and (±)tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors
60. Effects of imipramine on raphe nuclei and prefrontal cortex extracellular serotonin levels in the rat
61. Chronic electroconvulsive shock and 5-HT autoreceptor activity in the rat brain: An in vivo microdialysis study
62. Racemic pindolol induces a regionally selective, 5-HT(1A) (auto)receptor-mediated decrease of 5-HT release in the rat brain in vivo
63. Pindolol increases extracellular serotonin levels in freely moving cats at doses which suppress serotonergic neuronal activity
64. (-)Pindolol increases dialysate concentrations of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely-moving rats
65. Effect of pindolol on hormone secretion and body temperature: Partial agonist effects
66. Effect of ergotamine on serotonin-mediated responses in the rodent and human brain
67. Effects of long-term administration of venlafaxine on the function of pre- and postsynaptic 5-HT and NE receptors in the rat hippocampus
68. Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments
69. Pindolol treatment and major affective disorders: A three-year follow-up study of 30485 patients